Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[rituximab]1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 11, 14 💬
2Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab (rituximab-blit),
Tocilizumab		3件: Tocilizumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Abatacept 💬 		4件: CD80,
CD86,
IL6R,
MS4A1 💬 		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
3ABP 798 - Biosimilar to rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
4ABP 798 Biosimilar to Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
5Addition of rituximab if recurrence1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 11 💬
6Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab (rituximab-blit)		3件: Methylprednisolone ,
Methylprednisolone acetate ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51 💬
7Alemtuzumab and Rituximab2件: Alemtuzumab,
Rituximab (rituximab-blit)		2件: Alemtuzumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 60 💬
8Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab (rituximab-blit)		2件: Alemtuzumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
9Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)3件: Ocrelizumab,
Ofatumumab,
Rituximab (rituximab-blit)		3件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Ocrelizumab ,
Ofatumumab 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
10Belimumab in SLE patients / Rituximab in RA patients2件: Belimumab,
Rituximab (rituximab-blit)		2件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
11Bendamustine, Rituximab2件: Bendamustine,
Rituximab (rituximab-blit)		4件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 61 💬
12Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab (rituximab-blit)		6件: Azathioprine ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Azathioprine sodium ,
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35 💬
13Combination of Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
14Combination of Rituximab with subcutaneous belimumab2件: Belimumab,
Rituximab (rituximab-blit)		2件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
15Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 85 💬
16Cyclophosphamide/Rituximab2件: Cyclophosphamide,
Rituximab (rituximab-blit)		3件: Cyclophosphamide ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
17Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab (rituximab-blit)		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
18Diagnostic Test: Zirconium Zr 89 labelled rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 41 💬
19Double-Blind Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 51 💬
20Dr. Reddy’s Rituximab (DRL_RI) 100mg1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
21Dr. Reddy’s Rituximab (DRL_RI) 500mg1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
22Eltrombopag combining rituximab2件: Eltrombopag,
Rituximab (rituximab-blit)		3件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Eltrombopag olamine ,
Eltrombopag choline 💬 		2件: MPL,
MS4A1 💬 		4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
23Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab4件: Abatacept,
Rituximab (rituximab-blit),
Sarilumab,
Tocilizumab		4件: Tocilizumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Abatacept ,
Sarilumab 💬 		4件: CD80,
CD86,
IL6R,
MS4A1 💬 		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
24Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
25GP2013 - A Proposed biosimilar rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
26Higher Dose of Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
27IDEC-C2B8 (rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
28Immunosuppressive treatment (eg, rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 64 💬
29Individualized dose of rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 49 💬
30Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab (rituximab-blit),
Teriflunomide		13件: Cladribine ,
Alemtuzumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dimethyl fumarate ,
Fingolimod hydrochloride ,
Glatiramer acetate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate 💬 		26件: DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬 		58件: Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 13 💬
31Intravenous Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 66 💬
32Low-dose rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
33MabionCD20 (candidate biosimilar to rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
34MabThera (Rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 13, 46, 49, 53 💬
35Mabthera or biosimilar Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 48, 61 💬
36Mabthera or biosimilar rituximab product1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
37MabThera® (rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
38Originator rituximab - Rituxan ® or MabThera ®1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
39Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq8件: Alemtuzumab,
Cladribine,
Hyaluronidase,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Rituximab (rituximab-blit),
Ublituximab		10件: Cladribine ,
Alemtuzumab ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Hyaluronidase ,
Hyaluronidase ,
Ocrelizumab ,
Hyaluronidase ,
Natalizumab ,
Ofatumumab ,
Ublituximab 💬 		3件: ITGA4,
MS4A1,
RRM1 💬 		21件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
40Perfusion of treatment Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
41Prednisone, low dose rituximab2件: Prednisone,
Rituximab (rituximab-blit)		2件: Prednisone ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
42RhTPO in combination with Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
43Rituxan (INN: Rituximab), brand name in the United States1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
44Rituxan (INN: Rituximab), brand name in the US1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
45Rituxan (rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 49 💬
46Rituxan® (rituximab)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
47RITUXIMAB1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
48Rituximab (active comparator)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
49Rituximab (anti-CD20)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 53 💬
50Rituximab (Arm A)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 43, 44 💬
51Rituximab (Arm B)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 43, 44, 63 💬
52Rituximab (EU)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
53Rituximab (genetical recombination)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 14, 222, 223 💬
54Rituximab (MABTHERA and BIOSIMILARS)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 35, 162 💬
55Rituximab (Mabthera ®) Belimumab (Benlysta ®)2件: Belimumab,
Rituximab (rituximab-blit)		2件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
56Rituximab (Mabthera)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 14, 63 💬
57Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 35, 61, 63 💬
58Rituximab (Mabthera®)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 61 💬
59Rituximab (R)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 43, 44 💬
60Rituximab (Rituxan)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 11 💬
61Rituximab (RTX) and Azathioprine (AZA)2件: Azathioprine,
Rituximab (rituximab-blit)		3件: Azathioprine ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Azathioprine sodium 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 65 💬
62Rituximab (US)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
63Rituximab - MabThera1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
64Rituximab 1g IV1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
65Rituximab 1g/6months1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
66Rituximab 200mg/6months1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
67Rituximab [MabThera/Rituxan]1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
68Rituximab [MabThera]1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
69Rituximab and Cyclophosphamide IV2件: Cyclophosphamide,
Rituximab (rituximab-blit)		3件: Cyclophosphamide ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 35 💬
70Rituximab and dexamethasone2件: Dexamethasone,
Rituximab (rituximab-blit)		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
71Rituximab and Hyaluronidase Human2件: Hyaluronidase,
Rituximab (rituximab-blit)		4件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 331 💬
72Rituximab Biosimilar1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
73Rituximab Biosimilar ABP 7981件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
74Rituximab combined with corticosteroids1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
75Rituximab combined with Daratumumab(Anti-CD38 Monoclonal Antibody)2件: Daratumumab,
Rituximab (rituximab-blit)		2件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Daratumumab 💬 		2件: CD38,
MS4A1 💬 		6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 63 💬
76Rituximab combined with Omalizumab2件: Omalizumab,
Rituximab (rituximab-blit)		2件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Omalizumab 💬 		2件: FCER1A,
MS4A1 💬 		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162 💬
77Rituximab combined with tacrolimus induction + rituximab maintenance2件: Rituximab (rituximab-blit),
Tacrolimus		3件: Tacrolimus ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Tacrolimus 💬 		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
78Rituximab combined with tacrolimus induction + tacrolimus maintenance2件: Rituximab (rituximab-blit),
Tacrolimus		3件: Tacrolimus ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Tacrolimus 💬 		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
79Rituximab Infusion1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 222, 223 💬
80Rituximab Injection1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 11, 35, 222 💬
81Rituximab IT1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
82Rituximab IV1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
83Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
84Rituximab MabThera1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
85Rituximab plus methylprednisolone2件: Methylprednisolone,
Rituximab (rituximab-blit)		3件: Methylprednisolone ,
Methylprednisolone acetate ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
86Rituximab(RTX)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
87Rituximab, Cyclophosphamide, and Corticosteroids2件: Cyclophosphamide,
Rituximab (rituximab-blit)		3件: Cyclophosphamide ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
88Rituximab, Mabthera1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 53 💬
89Rituximab, MTX, folic acid2件: Folic acid,
Rituximab (rituximab-blit)		3件: Folic acid ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx),
Folate sodium 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
90Rituximab, observational study amon patients with active RA1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
91Rituximab-EU+ Rituximab-Pfizer x 2 Courses1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
92Rituximab-Pfizer1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
93Rituximab-Pfizer (PF-05280586) x 3 courses1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
94Rituximab-US + Rituximab-Pfizer x 2 Courses1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
95Rituximab/ Mabthera1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 271 💬
96SAIT101 (proposed rituximab biosimilar)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
97SAIT101 (rituximab biosimilar)1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
98Sequential treatment with rituximab and cladribine2件: Cladribine,
Rituximab (rituximab-blit)		2件: Cladribine ,
Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 		2件: MS4A1,
RRM1 💬 		5件: Drug metabolism - other enzymes, Glutathione metabolism, Hematopoietic cell lineage, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
99Single infusion of Rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
100Standard dose of rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 49 💬
101The Standard Steroid Treatment, Plasma Exchange and rituximab1件: Rituximab (rituximab-blit)1件: Rituximab (Rituximab, Rituximab-abbs, Rituximab-pvvr, Rituximab-arrx) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 85 💬